To test this hypothesis, we will analyze MRPL23 expression levels in ccRCC using both proprietary and public datasets, focusing on their impact on clinicopathological features and overall survival (OS) in ccRCC patients [17]. This evidence concerns the gene MRPL23 and nonpapillary renal cell carcinoma.